Precision Optics Corp Inc (POCI)
6.59
-0.06
(-0.90%)
USD |
NASDAQ |
May 16, 16:00
6.51
-0.08
(-1.21%)
After-Hours: 20:00
Precision Optics Enterprise Value: 41.44M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 41.44M |
May 15, 2024 | 41.80M |
May 14, 2024 | 38.65M |
May 13, 2024 | 38.83M |
May 10, 2024 | 38.28M |
May 09, 2024 | 38.34M |
May 08, 2024 | 36.13M |
May 07, 2024 | 35.67M |
May 06, 2024 | 35.73M |
May 03, 2024 | 34.28M |
May 02, 2024 | 35.13M |
May 01, 2024 | 35.73M |
April 30, 2024 | 35.43M |
April 29, 2024 | 35.43M |
April 26, 2024 | 35.43M |
April 25, 2024 | 35.85M |
April 24, 2024 | 35.22M |
April 23, 2024 | 35.07M |
April 22, 2024 | 34.82M |
April 19, 2024 | 34.83M |
April 18, 2024 | 34.82M |
April 17, 2024 | 34.89M |
April 16, 2024 | 34.58M |
April 15, 2024 | 34.58M |
April 12, 2024 | 34.58M |
Date | Value |
---|---|
April 11, 2024 | 33.97M |
April 10, 2024 | 35.03M |
April 09, 2024 | 35.03M |
April 08, 2024 | 35.22M |
April 05, 2024 | 35.44M |
April 04, 2024 | 35.98M |
April 03, 2024 | 36.10M |
April 02, 2024 | 36.16M |
April 01, 2024 | 36.16M |
March 28, 2024 | 35.13M |
March 27, 2024 | 35.00M |
March 26, 2024 | 37.09M |
March 25, 2024 | 37.25M |
March 22, 2024 | 37.55M |
March 21, 2024 | 35.49M |
March 20, 2024 | 37.67M |
March 19, 2024 | 35.79M |
March 18, 2024 | 35.31M |
March 15, 2024 | 37.07M |
March 14, 2024 | 36.28M |
March 13, 2024 | 35.61M |
March 12, 2024 | 35.37M |
March 11, 2024 | 35.43M |
March 08, 2024 | 36.16M |
March 07, 2024 | 35.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.11M
Minimum
Jul 24 2019
43.95M
Maximum
Jan 04 2022
27.77M
Average
29.60M
Median
Enterprise Value Benchmarks
AptarGroup Inc | 10.71B |
Daxor Corp | 46.42M |
Sanara MedTech Inc | 280.01M |
Warby Parker Inc | 1.698B |
Perspective Therapeutics Inc | 890.47M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.7588M |
Revenue (Quarterly) | 4.824M |
Total Expenses (Quarterly) | 5.528M |
EPS Diluted (Quarterly) | -0.13 |
Gross Profit Margin (Quarterly) | 30.08% |
Profit Margin (Quarterly) | -15.73% |
Earnings Yield | -4.55% |
Normalized Earnings Yield | -6.447 |